SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000886163-17-000127
Filing Date
2017-11-09
Accepted
2017-11-09 16:08:48
Documents
48
Period of Report
2017-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q lgnd-9301710q.htm 10-Q 947444
2 EXHIBIT 31.1 lgnd_93017exhibit311.htm EX-31.1 16493
3 EXHIBIT 31.2 lgnd_93017exhibit312.htm EX-31.2 16390
4 EXHIBIT 32.1 lgnd_93017exhibit321.htm EX-32.1 15626
  Complete submission text file 0000886163-17-000127.txt   5227172

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT lgnd-20170930.xml EX-101.INS 1106350
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT lgnd-20170930.xsd EX-101.SCH 34240
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT lgnd-20170930_cal.xml EX-101.CAL 80020
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT lgnd-20170930_def.xml EX-101.DEF 200541
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT lgnd-20170930_lab.xml EX-101.LAB 567713
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT lgnd-20170930_pre.xml EX-101.PRE 305634
Mailing Address 3911 SORRENTO VALLEY BLVD SUITE 110 SAN DIEGO CA 92121
Business Address 3911 SORRENTO VALLEY BLVD SUITE 110 SAN DIEGO CA 92121 858-550-7500
LIGAND PHARMACEUTICALS INC (Filer) CIK: 0000886163 (see all company filings)

IRS No.: 770160744 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-33093 | Film No.: 171190874
SIC: 2834 Pharmaceutical Preparations